December 20, 2024

POI Guidelines See First Major Update Since 2015

Four medical societies have revised their diagnostic criteria for premature ovarian insufficiency, now requiring only one elevated FSH test instead of two, while reporting a higher than previously known prevalence rate of 3.5% among women.

Conexiant

December 18, 2024

USPSTF Challenges Common Supplement Use

"Unfortunately, when we reviewed the latest evidence, we found that taking vitamin D with or without calcium does not prevent falls or fractures in older adults."

Conexiant

December 16, 2024

Menopause Treatment Shows No Brain Effects After Decade

Large continuation study challenges 'critical window' hypothesis by showing cognitive performance was unaffected by hormone therapy timing, formulation choice, or duration.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

December 11, 2024

Pro-inflammatory Diet May Weaken Women's Bones

Study finds that hypertensive women consuming pro-inflammatory diets are at an increased risk of osteopenia due to lower lumbar vertebrae bone mineral density.

Conexiant

December 11, 2024

Sex Differences in Statin-Linked Diabetes Risk

Study finds women are nearly twice as likely as men to report statin-associated diabetes mellitus, with atorvastatin showing the highest reporting disparity, according to Food and Drug Administration’s Adverse Event Reporting System data.

Conexiant

December 11, 2024

Osteosarcopenia: Stiffness-Balance Link

A study on postmenopausal women reveals significant reductions in muscle-tendon stiffness and balance control in osteosarcopenia, emphasizing the importance of targeted rehabilitation exercises. (Source: Aging Clinical and Experimental Research)

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant

December 09, 2024

Breast Calcifications Linked to CVD Risk

A recent study found that women with breast arterial calcification detected on mammograms face an approximately 50% increase in risk of cardiovascular events and mortality. The findings suggest that BAC may serve as an early marker of cardiovascular disease risk.

Conexiant